The FDA is expected to decide on treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity.

Adults aged 75 years or older should receive an RSV protein subunit vaccine; receipt can be considered for those aged 60 to 74 years at increased risk ...

HealthDay News — Adults with overweight or obesity regain much of their lost weight after cessation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a review published online ...

Collagen supplementation consistently associated with favorable outcomes for skin, musculoskeletal health, osteoarthritis conditions.

No significant improvement seen in overall survival with addition of hormone therapy to post-radical prostatectomy radiotherapy.

Testosterone replacement therapy (TRT) before total knee arthroplasty (TKA) is associated with an increased risk for medical and periprosthetic complications, a ...

Sucrose with or without non-nutritive sucking appears to reduce pain intensity during and 30 seconds after venipuncture.

Glenmark to launch the first generic version of Flovent HFA, expanding affordable access; achondroplasia treatment granted accelerated approval; Dupixent approved for allergic fungal rhinosinusitis; ...

Odds of prescription rise with increasing age, increasing BMI, abnormal lab testing, non-Hispanic White or Hispanic race, ethnicity ...

School-based cohort had lower risk for cervical cancer compared with the opportunistic cohort after adjustment for covariates.

Imlifidase is a Streptococcus pyogenes-derived cysteine protease that rapidly degrades immunoglobulin G antibodies within 2 to 6 hours of administration.

In the phase 3 VERIFY trial, rusfertide was associated with a significantly higher proportion of patients achieving clinical response compared with placebo.